CN111407897A - 基于荧光染料与考马斯亮蓝共结合的亲和素纳米粒及其制备方法和在构建肿瘤疫苗中的应用 - Google Patents
基于荧光染料与考马斯亮蓝共结合的亲和素纳米粒及其制备方法和在构建肿瘤疫苗中的应用 Download PDFInfo
- Publication number
- CN111407897A CN111407897A CN202010223065.8A CN202010223065A CN111407897A CN 111407897 A CN111407897 A CN 111407897A CN 202010223065 A CN202010223065 A CN 202010223065A CN 111407897 A CN111407897 A CN 111407897A
- Authority
- CN
- China
- Prior art keywords
- avidin
- fluorescent dye
- brilliant blue
- coomassie brilliant
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
- A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
- A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Optics & Photonics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010223065.8A CN111407897B (zh) | 2020-03-26 | 2020-03-26 | 基于荧光染料与考马斯亮蓝共结合的亲和素纳米粒及其制备方法和在构建肿瘤疫苗中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010223065.8A CN111407897B (zh) | 2020-03-26 | 2020-03-26 | 基于荧光染料与考马斯亮蓝共结合的亲和素纳米粒及其制备方法和在构建肿瘤疫苗中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111407897A true CN111407897A (zh) | 2020-07-14 |
CN111407897B CN111407897B (zh) | 2023-01-31 |
Family
ID=71486392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010223065.8A Active CN111407897B (zh) | 2020-03-26 | 2020-03-26 | 基于荧光染料与考马斯亮蓝共结合的亲和素纳米粒及其制备方法和在构建肿瘤疫苗中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111407897B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108210923A (zh) * | 2018-01-30 | 2018-06-29 | 海南医学院 | 一种荧光染料与考马斯亮蓝共结合的血清白蛋白纳米粒及其制备方法和在肿瘤诊疗中应用 |
-
2020
- 2020-03-26 CN CN202010223065.8A patent/CN111407897B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108210923A (zh) * | 2018-01-30 | 2018-06-29 | 海南医学院 | 一种荧光染料与考马斯亮蓝共结合的血清白蛋白纳米粒及其制备方法和在肿瘤诊疗中应用 |
Non-Patent Citations (2)
Title |
---|
AKSHAY JAIN等: "The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis", 《JOURNAL OF CONTROLLED RELEASE》 * |
XIUWEN GUAN等: "Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase", 《BIOMATERIALS》 * |
Also Published As
Publication number | Publication date |
---|---|
CN111407897B (zh) | 2023-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shang et al. | Nanomedicine-based tumor photothermal therapy synergized immunotherapy | |
Chang et al. | Supramolecular immunotherapy of cancer based on the self‐assembling peptide design | |
CN110124018B (zh) | 一种模拟坏死肿瘤细胞的磷酸钙-脂质纳米疫苗及其应用 | |
JP5579586B2 (ja) | 腫瘍ワクチン | |
Häring et al. | Magnetic gel composites for hyperthermia cancer therapy | |
CN106795517A (zh) | 基于rna的组合物及用于预防性和治疗性疗法的佐剂 | |
Zhang et al. | Locally injectable hydrogels for tumor immunotherapy | |
Chen et al. | Adoptive cellular immunotherapy of tumors via effective CpG delivery to dendritic cells using dendrimer-entrapped gold nanoparticles as a gene vector | |
CN103910802B (zh) | 一种促进树突细胞摄取抗原肽的多肽、促进树突细胞摄取抗原肽的纳米颗粒及其应用 | |
Persano et al. | Magnetic nanostructures as emerging therapeutic tools to boost anti-tumour immunity | |
WO2021077770A1 (zh) | 一种迷你联合佐剂纳米颗粒及其制备方法和应用 | |
CN105477630B (zh) | 一种同时实现促进树突细胞迁移至淋巴结和多模式成像的方法 | |
WO2023010777A1 (zh) | 基于淋巴细胞的同源靶向性人工抗原呈递细胞及其构建和应用 | |
Xu et al. | Potential of ferritin-based platforms for tumor immunotherapy | |
CN107867677B (zh) | 一维磷酸钙纳米/微米材料及其制备方法和应用 | |
Peng et al. | Research progress of the engagement of inorganic nanomaterials in cancer immunotherapy | |
Li et al. | Surgically derived cancer cell membrane-coated R837-loaded Poly (2-Oxazoline) nanoparticles for prostate cancer immunotherapy | |
Nie et al. | A single-shot prophylactic tumor vaccine enabled by an injectable biomembrane hydrogel | |
CN111407897B (zh) | 基于荧光染料与考马斯亮蓝共结合的亲和素纳米粒及其制备方法和在构建肿瘤疫苗中的应用 | |
CN107029236B (zh) | 一种吲哚菁绿自组装纳米疫苗及制备方法 | |
JPWO2014034669A1 (ja) | 非極性溶媒に分散性を有する細菌菌体成分を内封する脂質膜構造体およびその製造方法 | |
CN113769075B (zh) | 一种原位疫苗及其制备方法 | |
CN108452299A (zh) | 一种脂质体的制备方法及制作脂质体佐剂的方法 | |
CN110101853B (zh) | 蒲公英型异质纳米囊泡及其应用 | |
JP4688254B2 (ja) | 腫瘍ワクチン |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Liming Inventor after: Lv Zhuoxuan Inventor after: Zhang Yanwei Inventor after: Tan Guanghong Inventor after: Huang Fengying Inventor after: Cao Rong Inventor before: Zhang Liming Inventor before: Lv Zhuoxuan Inventor before: Tan Guanghong Inventor before: Huang Fengying Inventor before: Cao Rong |
|
GR01 | Patent grant | ||
GR01 | Patent grant |